ORIC Pharmaceuticals, Inc.
ORIC
$13.87
$0.151.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.49M | -35.77M | -30.51M | -32.59M | -36.36M |
| Total Depreciation and Amortization | 264.00K | 270.00K | 320.00K | 288.00K | 310.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.38M | 7.06M | 6.04M | 5.04M | 5.98M |
| Change in Net Operating Assets | 2.24M | -4.00M | 1.66M | 2.14M | -780.00K |
| Cash from Operations | -31.61M | -32.44M | -22.48M | -25.11M | -30.84M |
| Capital Expenditure | -356.00K | -2.00K | -227.00K | -35.00K | -63.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.22M | -17.97M | 17.21M | -110.50M | -76.87M |
| Cash from Investing | 11.86M | -17.98M | 16.98M | -110.54M | -76.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 828.00K | 62.13M | 1.50M | 111.19M | 134.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -993.00K | 0.00 | -1.74M | -414.00K |
| Cash from Financing | 828.00K | 61.14M | 1.50M | 109.45M | 134.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.91M | 10.73M | -4.00M | -26.20M | 26.53M |